Ricarda Brandes
Medical University of Vienna
5 Papers
Ricarda Brandes is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Antibody & Autoantibody. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Renate Kain,Markus Exner,Ricarda Brandes,Reinhard Ziebermayr,Reinhard Ziebermayr,Dawn Cunningham,Carol A. Alderson,Agnes Davidovits,Ingrid Raab,Renate Jahn,Renate Jahn,Oliver Ashour,Susanne Spitzauer,Gere Sunder-Plassmann,Minoru Fukuda,Per Klemm,Andrew J. Rees,Andrew J. Rees,Dontscho Kerjaschki +18 more
TL;DR: FimH-triggered autoimmunity to LAMP-2 provides a previously undescribed clinically relevant molecular mechanism for the development of pauci-immune FNGN.
460
Autoantibodies to hLAMP-2 in ANCA-Negative Pauci-Immune Focal Necrotizing GN
Andrea Peschel,Neil Basu,Alexandra Benharkou,Ricarda Brandes,Markus Brown,Régis Dieckmann,Andrew J. Rees,Renate Kain +7 more
TL;DR: In patients with ANCA-negative piFNGN, autoantibodies to hLAMP-2 that bind native glomerular but not neutrophil hLamp-2 are identified, suggesting a role in pathogenesis.
Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations.
T. Feenstra,Mariane Schmidt Thøgersen,E. Wieser,Andrea Peschel,Miriam J. Ball,Ricarda Brandes,Simon C. Satchell,T. Stockner,Frank Møller Aarestrup,Andrew J. Rees,Renate Kain +10 more
TL;DR: It is demonstrated that FimH residues E50 and T53 are crucial for adhesion under flow conditions, which provides novel insights into screening methods to determine the effect of FIMH mutants and potentially Fim H antagonists.
E-233 Propranolol as a potentially novel treatment of arteriovenous malformations: from bench to bedside
Sepide Kashefiolasl,Matthias S. Leisegang,R. Patel,P. Kan,Christian Foerch,R du Mesnil,V. Seifert,Ricarda Brandes,Valentina Prinz,Marcus Czabanka,J. Burkhardt,Juergen Konczalla +11 more
- 01 Jul 2022
TL;DR: In this paper , the vasoconstrictive and antiangiogenic effects of propranolol led the authors to explore its potential application for the treatment of AVMs.
High Prevalence of Autoantibodies to hLAMP-2 in Anti–Neutrophil Cytoplasmic Antibody–Associated Vasculitis
Renate Kain,Henko Tadema,Eoin F. McKinney,Alexandra Benharkou,Ricarda Brandes,Andrea Peschel,Virginie Hubert,Tjerk Feenstra,Gürkan Sengölge,Coen A. Stegeman,Peter Heeringa,Paul A. Lyons,Kenneth G. C. Smith,Cees G. M. Kallenberg,Andrew J. Rees +14 more
TL;DR: In this paper, the involvement of autoantibodies to human lysosome-associated membrane protein-2 (hLAMP-2) in anti-neutrophil cytoplasmic antibody-associated vasculitis is controversial because of the absence of confirmatory data subsequent to the initial reports of their high prevalence in this disease.